
### [NCIT:C4810](http://purl.obolibrary.org/obo/NCIT_C4810)
**Label:** Malignant Sweat Gland Neoplasm

**Subclasses:** [NCIT:C27255](http://purl.obolibrary.org/obo/NCIT_C27255) (Eccrine Carcinoma), [NCIT:C27533](http://purl.obolibrary.org/obo/NCIT_C27533) (Primary Cutaneous Mucinous Carcinoma), [NCIT:C27254](http://purl.obolibrary.org/obo/NCIT_C27254) (Papillary Eccrine Carcinoma), [NCIT:C4472](http://purl.obolibrary.org/obo/NCIT_C4472) (Mucoepidermoid Skin Carcinoma), [NCIT:C40308](http://purl.obolibrary.org/obo/NCIT_C40308) (Vulvar Apocrine Adenocarcinoma), [NCIT:C40306](http://purl.obolibrary.org/obo/NCIT_C40306) (Vulvar Eccrine Porocarcinoma), [NCIT:C40307](http://purl.obolibrary.org/obo/NCIT_C40307) (Vulvar Clear Cell Hidradenocarcinoma), [NCIT:C43344](http://purl.obolibrary.org/obo/NCIT_C43344) (Carcinoma ex Eccrine Spiradenoma), [NCIT:C40304](http://purl.obolibrary.org/obo/NCIT_C40304) (Malignant Vulvar Sweat Gland Neoplasm), [NCIT:C43345](http://purl.obolibrary.org/obo/NCIT_C43345) (Ductal Eccrine Adenocarcinoma), [NCIT:C40305](http://purl.obolibrary.org/obo/NCIT_C40305) (Vulvar Eccrine Adenocarcinoma), [NCIT:C3682](http://purl.obolibrary.org/obo/NCIT_C3682) (Sweat Gland Tubular Carcinoma), [NCIT:C43346](http://purl.obolibrary.org/obo/NCIT_C43346) (Ductal Eccrine Carcinoma with Spindle Cell Elements), [NCIT:C7581](http://purl.obolibrary.org/obo/NCIT_C7581) (Microcystic Adnexal Carcinoma), [NCIT:C5140](http://purl.obolibrary.org/obo/NCIT_C5140) (Apocrine Breast Carcinoma In Situ), [NCIT:C5141](http://purl.obolibrary.org/obo/NCIT_C5141) (Apocrine Breast Carcinoma), [NCIT:C43347](http://purl.obolibrary.org/obo/NCIT_C43347) (Ductal Eccrine Carcinoma with Squamous Metaplasia), [NCIT:C4471](http://purl.obolibrary.org/obo/NCIT_C4471) (Adenoid Cystic Skin Carcinoma), [NCIT:C5560](http://purl.obolibrary.org/obo/NCIT_C5560) (Eccrine Porocarcinoma), [NCIT:C6938](http://purl.obolibrary.org/obo/NCIT_C6938) (Sweat Gland Carcinoma), [NCIT:C128164](http://purl.obolibrary.org/obo/NCIT_C128164) (Vulvar Adenocarcinoma of Sweat Gland Type), [NCIT:C5559](http://purl.obolibrary.org/obo/NCIT_C5559) (Malignant Eccrine Neoplasm), [NCIT:C54664](http://purl.obolibrary.org/obo/NCIT_C54664) (Hidradenocarcinoma), [NCIT:C4169](http://purl.obolibrary.org/obo/NCIT_C4169) (Apocrine Carcinoma), [NCIT:C4027](http://purl.obolibrary.org/obo/NCIT_C4027) (Paget Disease of the Vulva), [NCIT:C5457](http://purl.obolibrary.org/obo/NCIT_C5457) (Invasive Apocrine Breast Carcinoma), [NCIT:C6800](http://purl.obolibrary.org/obo/NCIT_C6800) (Malignant Apocrine Neoplasm), [NCIT:C5117](http://purl.obolibrary.org/obo/NCIT_C5117) (Spiradenocarcinoma), [NCIT:C5180](http://purl.obolibrary.org/obo/NCIT_C5180) (Malignant Breast Eccrine Spiradenoma), 

**Class expressions from DL-Learner:**

- [UBERON:0002330](http://purl.obolibrary.org/obo/UBERON_0002330) (exocrine system) 58.33%
- [UBERON:0002097](http://purl.obolibrary.org/obo/UBERON_0002097) (skin of body) 58.33%
- [NCIT:C36156](http://purl.obolibrary.org/obo/NCIT_C36156) (Favorable Clinical Outcome) 58.33%
- Thing 51.96%
- [UBERON:0001820](http://purl.obolibrary.org/obo/UBERON_0001820) (sweat gland) 30.69%
- [UBERON:0000061](http://purl.obolibrary.org/obo/UBERON_0000061) (anatomical structure) 27.90%
- [UBERON:0000465](http://purl.obolibrary.org/obo/UBERON_0000465) (material anatomical entity) 27.80%
- [BFO:0000040](http://purl.obolibrary.org/obo/BFO_0000040) (material entity) 27.63%
- [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 27.63%
- [BFO:0000004](http://purl.obolibrary.org/obo/BFO_0000004) (null) 27.47%
- [BFO:0000002](http://purl.obolibrary.org/obo/BFO_0000002) (null) 27.46%
- [UBERON:0007771](http://purl.obolibrary.org/obo/UBERON_0007771) (epidermis gland) 26.01%
- [UBERON:0002419](http://purl.obolibrary.org/obo/UBERON_0002419) (skin gland) 25.00%
- [UBERON:0004121](http://purl.obolibrary.org/obo/UBERON_0004121) (ectoderm-derived structure) 22.01%
- [UBERON:0010000](http://purl.obolibrary.org/obo/UBERON_0010000) (multicellular anatomical structure) 19.11%


